Jellinger and Lerman, MD PA dba The Center for Diabetes and Endocrine Care

Public research footprint of Jellinger and Lerman, MD PA dba The Center for Diabetes and Endocrine Care, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Atherosclerotic Cardiovascular Disease (ASCVD) · Type 2 Diabetes Mellitus · Chronic Kidney Disease (CKD) · Coronary Heart Disease (CHD)

Recently updated registry entries

NCT07613294 — A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With… (Recruiting)
NCT06292013 — A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse… (Active Not Recruiting)
NCT06383390 — The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in… (Active Not Recruiting)

Work at Jellinger and Lerman, MD PA dba The Center for Diabetes and Endocrine Care?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.